JS04.5.A HEMIZYGOUSCDKN2A DELETION CONFERS WORSE SURVIVAL OUTCOMES IN IDH-MUTANT GLIOMAS
Kocakavuk, E, Johnson, K C, Sabedot, T S, Reinhardt, H C, Noushmehr, H, Verhaak, R G W
Published in Neuro-oncology (Charlottesville, Va.) (08.09.2023)
Published in Neuro-oncology (Charlottesville, Va.) (08.09.2023)
Get full text
Journal Article
JS04.5.A HEMIZYGOUS CDKN2A DELETION CONFERS WORSE SURVIVAL OUTCOMES IN IDH-MUTANT GLIOMAS
Kocakavuk, E, Johnson, K C, Sabedot, T S, Reinhardt, H C, Noushmehr, H, Verhaak, R G W
Published in Neuro-oncology (Charlottesville, Va.) (08.09.2023)
Published in Neuro-oncology (Charlottesville, Va.) (08.09.2023)
Get full text
Journal Article
P13.15 DNA methylation abnormalities in non-promoter regulatory regions are associated with invasive behavior in pituitary tumors
Mosella, M Q S, Sabedot, T S, Malta, T M, Rock, J, Felicella, M, Aho, T, Noushmehr, H, Castro, A V
Published in Neuro-oncology (Charlottesville, Va.) (06.09.2019)
Published in Neuro-oncology (Charlottesville, Va.) (06.09.2019)
Get full text
Journal Article
P01.02 Serum-derived DNA methylation markers distinguish functional and invasiveness subtypes in patients harboring pituitary tumors
Castro, A V, Wells, M, Asmaro, K, Sabedot, T S, Mosella, M S, Malta, T M, Nelson, K, Snyder, J, deCarvalho, A, Mukherjee, A, Chitale, D, Robin, A, Rosenblum, M, Mikkelsen, T, Poisson, L M, Lee, I, Walbert, T, Bhan, A, Kalkanis, S, Rock, J, Noushmehr, H
Published in Neuro-oncology (Charlottesville, Va.) (06.09.2019)
Published in Neuro-oncology (Charlottesville, Va.) (06.09.2019)
Get full text
Journal Article